TITLE

ALS awareness. Disappointing

PUB. DATE
March 2012
SOURCE
PN;Mar2012, Vol. 66 Issue 3, p35
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Trophos SA has stated that the results from the Phase III study of its lead compound, olesoxime, did not demonstrate a significant increase in survival versus placebo in 512 patients with amyotrophic lateral sclerosis ( ALS) who also received riluzole.
ACCESSION #
71705163

 

Related Articles

  • Nutritional and Metabolic Support in Adults With Amyotrophic Lateral Sclerosis. McDonagh, Michelle // Perspectives on Swallowing & Swallowing Disorders (Dysphagia);Mar2013, Vol. 22 Issue 1, p12 

    Amyotrophic lateral sclerosis (ALS) is an incurable, degenerative, neuromuscular condition. Nutritional and metabolic support is an integral component of care for patients with ALS because those capable of maintaining a normal nutrition status exhibit a slower rate of disease progression....

  • Cell Transplantation Center of Excellence for Aging and Brain Repair.  // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1 

    The article focuses on a study according to which a combined, systematically delivered immunosuppression regimen of two drugs improves the survival of the human spinal stem cells. The researchers have tested four different immunosuppressive protocols to determine which regimen improved long-term...

  • Management of Sialorrhea in Amyotrophic Lateral Sclerosis #299. Scott, Kristin; Shannon, Robert; Roche-Green, Alva // Journal of Palliative Medicine;Jan2016, Vol. 19 Issue 1, p110 

    The article discusses a study on the management of sialorrhea symptoms in Amyotrophic Lateral Sclerosis (ALS) patients. Topics include nonpharmacologic and pharmacologic strategies such as medications including glycopyrrolate, scopolamine patches and tricyclic antidepressants as well as salivary...

  • A 7 YEAR RETROSPECTIVE EVALUATION OF INITIATION OF LONG TERM NON-INVASIVE VENTILATORY SUPPORT FOR MOTOR NEURONE DISEASE. Palmer, J.; Hughes, P. // Thorax;Dec2011 Supplement, pA178 

    In 2010 NICE (1) published it's guideline for the use of non-invasive ventilation in the management of motor neurone disease (MND). We have offered long-term non-invasive ventilation (NIV) in this patient group for 7 years. We have evaluated concordance data for all patients set-up during this...

  • Insulin-like growth factor significantly improves symptoms...  // Formulary;Jan1996, Vol. 31 Issue 1, p15 

    Reports that the recombinant human insulin-like growth factor appears to slow progression of amyotrophic lateral sclerosis (ALS) and improve functional ability according to the results of a survey. Side effects of drug; Dosage; Comment from Howard Natter, clinical assistant professor of...

  • EXONHIT INITIATES PHASE II CLINICAL TRIAL FOR EHT 0201.  // Worldwide Biotech;Dec2002, Vol. 14 Issue 12, p1 

    Reports on the launch by the company ExonHit Therapeutics of a clinical trial evaluating the effectiveness of EHT 0201 (pentoxyfylline) in patients suffering from amyotrophic lateral sclerosis.

  • Doe v. Wilson. Salyer, David R. // Issues in Law & Medicine;Winter90, Vol. 6 Issue 3, p319 

    Presents a United States court ruling related to euthanasia in patients suffering from amyotrophic lateral sclerosis. Case of patient Jane Doe who requested that her physician Dr. James P. Wilson disconnect her respirator; Consideration by Chancellor Allen High on previous legal precedents.

  • Support services important component of Rilutek launch. Rodgers, Katie // Drug Topics;2/5/96, Vol. 140 Issue 3, p46 

    Reports on the planned launch of Rhone-Poulenc Rhorer's (RPR) Rilutek riluzole drug for amyotrophic lateral sclerosis (ALS). Patient support services; Background information; Implications; Plans and expectations.

  • Diagnosing motor neurone disease. Chancellor, Andrew M. // BMJ: British Medical Journal (International Edition);3/16/96, Vol. 312 Issue 7032, p650 

    Discusses diagnostic strategies for motor neurone disease. Symptoms; Dilemma faced by the physician in diagnosing motor neurone disease; Conditions that resemble idiopathic motor neurone disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics